The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study is a paper indexed in PICO Portal from OpenAlex.
How many citations does The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study have?
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study has 14 citations in the OpenAlex counts PICO Portal stores.
When was The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study published?
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study has 2023 year in the PICO Portal index.
What is the open-access status of The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study?
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study has hybrid oa status in the PICO Portal index.
What is the DOI of The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study?
The DOI for The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study is on the source record.
What is the PMID of The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study?
The PMID for The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study is on the source record.
What is the OpenAlex record for The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study?
The OpenAlex for The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study is on the source record.